
About Globela Laboratories Private Limited
Data last updated:
Globela Laboratories Private Limited was a private limited company based in Surat, Gujarat, India, operated as a subsidiary of Globela Pharma Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 2022.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2022PTC129637. Its GSTIN is 24AAJCG6052E1ZT (Gujarat).
The company had an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹9.87 Cr. It was led by directors Bhanubhai Shambhubhai Vaghashia and Priyank Vaghashia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Plot No. 5536 Road No. 55 GIDC Sachin, Surat, Gujarat, India – 394230.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.13 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹1.17 Cr (net margin -2.5%) and EBITDA of ₹3.27 Cr (EBITDA margin 7.1%).
As per MCA filings, the company had open charges of ₹44.12 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The last known website on record is globelapharma.com.
Company details
Recognitions & Rankings of Globela Laboratories
Contact details
Globela Laboratories Private Limited's registered office is in Surat, Gujarat. Its website is globelapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 5536 Road No. 55 GIDC Sachin, Surat, Gujarat, India – 394230
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Globela Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Globela Laboratories are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Globela Laboratories Private Limited, buy the company report.
Financials of Globela Laboratories Private Limited
FY 2025 filings availableGlobela Laboratories Private Limited reported revenue of ₹46.13 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year. EBITDA fell 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.27 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.17 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.1% | |||
| Net Profit Margin | -2.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Globela Laboratories Private Limited, buy the company report.
Board of directors of Globela Laboratories Private Limited
Globela Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhanubhai Shambhubhai Vaghashia Also directs: Globela Pharma Private Limited, Globela Industries Private Limited | Director | 24 Feb 2022 | 4 Years 8 Months | As last reported |
| Priyank Vaghashia | Director | 24 Feb 2022 | 4 Years 8 Months | As last reported |
Peer comparison
Globela Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BKM Solvents Private Limited | ₹46.22 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Chemic Life Sciences Private Limited | ₹46.19 Cr (FY 2023) | -7.0% | Hyderabad, Telangana, India | |||
| Praveen Aroma Private Limited | ₹46.18 Cr (FY 2025) | -10.0% | New Delhi, Delhi, India | |||
| Yash Pharma Laboratories Private Limited | ₹46.17 Cr (FY 2025) | -35.0% | Thane, Maharashtra, India | |||
| Rednex Pharmaceuticals Limited | ₹46.14 Cr (FY 2025) | 88.0% | Bavla, Gujarat, India | |||
| Globela Laboratories Private Limitedthis company | ₹46.13 Cr (FY 2025) | -₹1.17 Cr | -2.5% | -2.0% | Surat, Gujarat, India | |
| Brilliant Lifesciences Private Limited | ₹46.12 Cr (FY 2025) | 103.0% | Detroj, Gujarat, India | |||
| Abhilasha Pharma Private Limited | ₹46.09 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Kimberlite Chemicals (India) Private Limited | ₹46.07 Cr (FY 2024) | 0.0% | Doddaballapura, Karnataka, India | |||
| Aumgene Biosciences Private Limited | ₹46.06 Cr (FY 2025) | 37.0% | Surat, Gujarat, India | |||
| Dee Bee Organics Pvt. Ltd | ₹46.05 Cr (FY 2025) | 0.0% | Alwar, Rajasthan, India |
To see the full peer comparison of Globela Laboratories Private Limited, buy the company report.
Auditor
Globela Laboratories Private Limited is audited by MSKA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & ASSOCIATES | FY 2023 | 105047W |
Shareholding
The shareholding of Globela Laboratories Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Globela Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Apr 2022 | 100569201 | Axis Bank Limited | ₹22.06 Cr | Open | |
| 25 Mar 2022 | 100554233 | Axis Bank Limited | ₹22.06 Cr | Open |
To see the full charge records of Globela Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Globela Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, SURAT, Gujarat | Court case (REFER T LC) | Filed against the company by an individual | Disposed |
To see the full case history of Globela Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Globela Laboratories Private Limited has 4 MSME Form 1 returns on record between 2022 and 2023, listing 68 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Sheth Impression LLP | |||
| Nexgen Pack |
To see the full MSME payment records of Globela Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Globela Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCG6052E1ZT | Gujarat | Active | 03 Mar 2022 |
To see the full GST registrations and return filing status of Globela Laboratories Private Limited, buy the company report.
Recent activity
Globela Laboratories Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Bhanubhai Shambhubhai Vaghashia was appointed as Director on 24 Feb 2022.
Frequently asked questions
Globela Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Globela Laboratories was a private limited company based in Surat, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 24 February 2022 and is registered under CIN U24304GJ2022PTC129637. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Globela Laboratories was incorporated on 24 February 2022. It is registered with the Registrar of Companies, Ahmedabad.
Globela Laboratories had 2 directors:
- Bhanubhai Shambhubhai Vaghashia - Director
- Priyank Vaghashia - Director
The CIN (Corporate Identification Number) of Globela Laboratories is U24304GJ2022PTC129637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Globela Laboratories is at Plot No. 5536 Road No. 55 GIDC Sachin, Surat, Gujarat, India – 394230.
Yes, Globela Laboratories is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Globela Laboratories can be reached through the website globelapharma.com. Its registered office is in Surat, Gujarat, India.
The latest financial statements of Globela Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Globela Laboratories is 24AAJCG6052E1ZT, registered in Gujarat.
Globela Laboratories operated in the pharma industry, in the drug formulation and development segment.
The peers of Globela Laboratories by revenue are BKM Solvents Private Limited, Chemic Life Sciences Private Limited, Praveen Aroma Private Limited, Yash Pharma Laboratories Private Limited, Rednex Pharmaceuticals Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

